Do you have a diagnosis or provisional diagnosis of :
Chronic Pain interfering with your functioning
• Severe Neuropathic pain,
• Chronic non-Cancer pain,
• Cancer pain,
• Headache,
• Migraine
Multiple Sclerosis (MS)
Amyotrophic Lateral Sclerosis (ALS) Spinal Cord Injury or Spinal Cord Disease Epilepsy (Seizures)
Alzheimer’s Disease, Dementia
Movement Disorders
• Cervical Dystonia/Spasmodic Torticollis,
• Huntington’s Disease,
• Parkinson’s Disease,
• Tourette’s Syndrome
Glaucoma
Arthritis, Musculoskeletal Disorders
• Osteoarthritis,
• Rheumatoid Arthritis,
• Fibromyalgia,
• Osteoporosis
Inclusion Body Myositis (IBM)
Asthma
Hypertension
Gastrointestinal System Disorders
• Irritable Bowel Syndrome,
• Inflammatory Bowel Diseases (Ulcerative Colitis, Crohn’s Disease),
• Hepatitis, Pancreatitis, Metabolic Syndrome/Obesity
Severe Nausea and Vomiting
Wasting Syndrome (Cachexia, e.g., tissue injury) Anorexia in HIV/AIDS/Cancer patients
Anorexia Nervosa
Psychiatric Disorders
• Anxiety,
• Depression,
• Sleep Disorders,
• Post-Traumatic Stress Disorder,
• Alcohol/Opiod withdrawal symptoms,
• Schizophrenia,
• Psychosis
Inflammatory Skin Diseases
If you have been diagnosed with one or more of the above conditions, please
provide our clinic with relevant Health Information from the Family Physician/ Specialist(s)/Health
Care Provider(s): i.e.

- Pertinent consult(s)/case assessment(s) report(s)

- A complete list of prescribed medication that has been tried or considered for conventional
treatment(s) and that has been found to be ineffective or medically inappropriate for the
treatment of the corresponding medical condition.

- All pertinent laboratory test(s), scans/imaging e.g.

Call Today For A Consultation: 1-844-424-7416

Executives exit Eight Capital after controversial marijuana deal

Executives exit Eight Capital after controversial marijuana deal
(Many states have some form of legalized access to marijuana – particularly for medical purposes – but there are still federal statutes that make the …
Source: Cannabis Executives exit Eight Capital after controversial marijuana deal